思路迪

“成为肿瘤精准医疗领域的创新型领导者”

制药/生物工程 / 500-1000人 / 福州、南宁、成都等地

新药研发

成员介绍

  • David Liu/CMO

    Engaged in research and development of oncology drugs for nearly 20 years with extensive training in both basic science and clinical medicine;Experienced in global clinical development of biologic and small molecules in both solid and blood malignancies. Former Executive Medical Director at Celgene USA; Former Group Medical Director at BMS

我们的团队

全球首个抗PD-L1单域抗体新药KN035连续推进在中、美、日三地的药物临床试验

新药研发团队在招职位

思路迪的其他团队